A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

NCT01053429 · clinicaltrials.gov ↗

COMPLETED

Status

3391

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder
Schizophrenia

Interventions

DRUG: ziprasidone

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.